Search Results for "Antidepressants"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Antidepressants. Results 51 to 60 of 185 total matches.
Citalopram (Celexa) and QT Interval Prolongation
The Medical Letter on Drugs and Therapeutics • Sep 03, 2012 (Issue 1398)
has asked the manufacturers of the selective
serotonin reuptake inhibitor (SSRI) antidepressant
citalopram ...
The FDA has asked the manufacturers of the selective
serotonin reuptake inhibitor (SSRI) antidepressant
citalopram (Celexa, and others) to revise the labeling
of the drug to include new warnings about the risk of
QT interval prolongation.
Citalopram, Escitalopram and the QT Interval
The Medical Letter on Drugs and Therapeutics • Jul 22, 2013 (Issue 1421)
),
may benefit from higher-than-recommended doses.
CHOICE OF AN ANTIDEPRESSANT — SSRIs are
usually the drugs ...
In 2011, the FDA asked the manufacturers of the selective
serotonin reuptake inhibitor (SSRI) citalopram
(Celexa, and generics) to lower the maximum daily
dosage of the drug because of a dose-related increase
in the QT interval. Since then, some of our readers
have asked whether escitalopram (Lexapro, and generics),
the active enantiomer of citalopram, could have the
same effect.
Lemborexant (Dayvigo) for Insomnia
The Medical Letter on Drugs and Therapeutics • Jun 29, 2020 (Issue 1601)
antidepressant
doxepin in low doses (Silenor, and generics), or
suvorexant may be more effective, but they can ...
The FDA has approved lemborexant (Dayvigo – Eisai),
an orexin receptor antagonist, for treatment of sleep-onset
and/or sleep-maintenance insomnia in adults. It
is the second orexin receptor antagonist to be approved
for this indication; suvorexant (Belsomra) was the first.
Safety of SSRIs in Pregnancy
The Medical Letter on Drugs and Therapeutics • Nov 17, 2008 (Issue 1299)
to antidepressants during pregnancy must be weighed against the risks of untreated
depression, which also include ...
Depression occurs in up to 20% of pregnant women, and the use of selective serotonin reuptake inhibitors (SSRIs) in these women has been increasing. Maternal depression has itself been associated with intrauterine growth problems and low birth weight, so the risks of exposure to antidepressants during pregnancy must be weighed against the risks of untreated depression, which also include self-harm, poor bonding and poor parenting. SSRIs available in the US for treatment of depression include citalopram (Celexa, and others), escitalopram (Lexapro), fluoxetine (Prozac, and others), paroxetine...
Clonidine for Treatment of Attention-Deficit/Hyperactivity Disorder
The Medical Letter on Drugs and Therapeutics • Dec 06, 1996 (Issue 989)
, abdominal pain and insomnia. Tricyclic antidepressants have
also been used, but can cause ...
Clonidine, an Alpha2-selective adrenergic agonist marketed in the USA only for treatment of hypertension, has also been used in recent years to treat children with attention-deficit/hyperactivity disorder (ADHD).
SAMe For Depression
The Medical Letter on Drugs and Therapeutics • Nov 05, 1999 (Issue 1065)
.
CLINICAL TRIALS — Clinical trials of antidepressant drugs should be at least six to eight
weeks long ...
S-adenosyl-methionine (SAM; SAMe; ademetionine; adomet), an endogenous compound synthesized from methionine and adenosine-triphosphate (ATP), has been marketed in stores and on the internet as a dietary supplement to promote "emotional well being."
Capsaicin Patch (Qutenza) for Postherpetic Neuralgia
The Medical Letter on Drugs and Therapeutics • May 30, 2011 (Issue 1365)
, and others) are
FDA-approved for treatment of postherpetic neuralgia.
2 Tricyclic antidepressants ...
The FDA has approved a topical 8% patch formulation
of capsaicin (Qutenza – NeurogesX), available only by
prescription, for local treatment of postherpetic neuralgia.
Postherpetic neuralgia occurs after herpes zoster
in about one third of patients ≥60 years old and can
persist for months or even years.
Table: Safety of Drugs for IBS in Pregnancy and Lactation (online only)
The Medical Letter on Drugs and Therapeutics • Mar 23, 2020 (Issue 1594)
not be used1
Tricyclic Antidepressants (TCAs)
(such as amitriptyline, desipramine
[Norpramin, and generics ...
View the Table: Safety of Drugs for IBS in Pregnancy and Lactation
Drugs for Irritable Bowel Syndrome
The Medical Letter on Drugs and Therapeutics • Mar 23, 2020 (Issue 1594)
or other antispasmodics can be used for
abdominal pain or postprandial symptoms.
Antidepressants (TCAs or SSRIs) can ...
Irritable bowel syndrome (IBS) is a common disorder
characterized by recurrent abdominal pain and altered
bowel habits, often accompanied by bloating.IBS
is classified according to the predominant bowel
symptom as IBS with constipation (IBS-C), IBS with
diarrhea (IBS-D), mixed type (IBS-M), or unclassified
(IBS-U). Alterations in the microbiome, stress
responses, sensory and motor function of the gut,
and host genetic factors may be contributing factors.
Since the exact cause of IBS is unknown, the goal of
treatment is symptom control.
Treatment of Xerostomia
The Medical Letter on Drugs and Therapeutics • Jul 29, 1988 (Issue 771)
of saliva and cause dry
mouth include anorectics, anticholinergics, antidepressants, antihistamines ...
Xerostomia, dry mouth due to decreased or absent saliva, is a common problem, particularly among elderly patients. Decreased salivary flow can be due to many different conditions, including drug therapy, Sj gren's syndrome (keratoconjunctivitis sicca) or radiation of the salivary glands.